Page History
National Immunisation Program (NIP) schedule for Shingles (see reference):
From 1 November 2023, the shingles vaccine Shingrix® replaced Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles.
A 2-dose course of Shingrix® will be available for free for:
- people aged 65 years and older
- First Nations people aged 50 years and older
- immunocompromised people aged 18 years and older with the following medical conditions:
- haemopoietic stem cell transplant
- solid organ transplant
- haematological malignancy
- advanced or untreated HIV.
Shingles Report:
Shingles graph provides a pie chart by immunisation status for population aged 18 and over.
To find eligible patients, please apply the filters as per the recipes attached below.
The categories provided are:
- Recorded
- Not Recorded
Warning | ||
---|---|---|
| ||
The updated report will be available to General Practices in end of November CAT release. Currently, the report identifies population aged 70 to 79 |
Recipes:
Please use the below recipes to find the eligible population for Shingles vaccination
Eligibility 1: people aged 65 years and older
View file | ||||
---|---|---|---|---|
|
Eligibility 2: First Nations people aged 50 years and older
View file | ||||
---|---|---|---|---|
|
Eligibility 3: immunocompromised people aged 18 years and older with the following medical conditions:
- haemopoietic stem cell transplant
- solid organ transplant
- haematological malignancy
- advanced or untreated HIV.
View file | ||||
---|---|---|---|---|
|
References:
Department of Health and Aged Care - Shingles (herpes zoster) vaccine
Australian Immunisation Handbook - Zoster (herpes zoster)